TY  - JOUR
AU  - Bernardo, Miquel
AU  - Rico-Villademoros, Fernando
AU  - Garcia-Rizo, Clemente
AU  - Rojo, Rosa
AU  - Gómez-Huelgas, Ricardo
PY  - 2021
DO  - 10.1007/s12325-021-01689-8
UR  - http://hdl.handle.net/10668/17537
T2  - Advances in therapy
AB  - To assess the risk of occurrence and potential determinants of metabolic disorders in adult patients treated with second-generation antipsychotics (SGAs) under real-world practice conditions. MEDLINE, EMBASE, and PsycInfo were searched in July 2019...
LA  - en
PB  - Springer
KW  - Antipsychotic
KW  - Diabetes
KW  - Dyslipidemia
KW  - Hyperosmolar hyperglycemic state
KW  - Hypertension
KW  - Ketoacidosis
KW  - Metabolic syndrome
KW  - Obesity
KW  - Weight gain
KW  - Adult
KW  - Antipsychotic agents
KW  - Clozapine
KW  - Humans
KW  - Olanzapine
KW  - Quetiapine fumarate
KW  - Risperidone
TI  - Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.
TY  - research article
VL  - 38
ER  -